Alan S. Wayne, MD

Title(s)Chair, Department of Pediatrics Professor of Pediatrics and Medicine, Keck School of Medicine of USC
SchoolKeck School of Medicine of Usc
AddressCHL Mail Stop 126
Off Campus
Los Angeles CA 90027
Phone+1 323 361 8670
vCardDownload vCard
    Other Positions
    Title(s)Pediatrician-in-Chief and Senior Vice President of Academic Affairs

    Title(s)Pasadena Guild Chair Children's Hospital Los Angeles


    Collapse Overview 
    Collapse Overview
    Alan S. Wayne, MD serves as Chair of the Department of Pediatrics at the Keck School of Medicine of USC and Senior Vice President of Academic Affairs and Pediatrician-in-Chief at Children's Hospital Los Angeles (CHLA). Dr. Wayne is Professor of Pediatrics and Medicine at the Keck School of Medicine of USC. In these roles, Dr. Wayne oversees the Department’s clinical care delivery, medical education, and research programs, and leads the departmental strategy, faculty affairs, and budget management in the context of the missions of USC and CHLA.

    Dr. Wayne’s primary research efforts are directed toward the development of new treatment approaches for leukemias and lymphomas, with a focus on targeted, immune-based, and cellular therapies. He is the Medical Director of the Therapeutic Advances in Childhood Leukemia/Lymphoma (TACL) Consortium, a multinational clinical trials group headquartered at CHLA. He has an ongoing leadership role in the development of genetically modified chimeric antigen receptor (CAR) T-cells for childhood hematologic malignancies. Additionally, he plays a leadership role in international efforts in the area of post-transplant relapse of hematologic malignancies, the primary aim of which is to study the biology, prevention, and treatment of relapse after hematopoietic stem cell transplantation.

    Board-certified in pediatric hematology-oncology, Dr. Wayne attended the Honors Program in Medical Education obtaining his BS and MD degrees from Northwestern University. He conducted internship, residency, and chief residency in pediatrics at Boston Children’s Hospital followed by pediatric hematology-oncology fellowship at Boston Children’s Hospital and the Dana-Farber Cancer Institute.

    Collapse Research 
    Collapse Research Activities and Funding
    USC Norris Comprehensive Cancer Center (Core) Grant
    NIH P30CA014089Apr 1, 1980 - Nov 30, 2021
    Role: Principal Investigator
    Pediatric Graft-vs-Host Disease
    NIH Z01BC010596
    Role: Principal Investigator
    Pediatric Oncology Branch Clinical Care and Education
    NIH Z01BC010764
    Role: Principal Investigator
    Experimental Therapeutics of Pediatric Hematopoietic Malignancies
    NIH Z01SC010353
    Role: Principal Investigator
    Pediatric Graft-vs-Host Disease
    NIH ZICBC010596
    Role: Principal Investigator
    Behavioral Science Core
    NIH ZICBC011288
    Role: Principal Investigator
    Experimental Therapeutics of Pediatric Hematopoietic Malignancies
    NIH ZICSC010353
    Role: Principal Investigator
    Pediatric Oncology Branch Clinical Care and Education
    NIH ZIEBC010764
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium. Cancers (Basel). 2024 Jan 24; 16(3). Verma A, Chi YY, Malvar J, Lamble A, Chaudhury S, Agarwal A, Li HT, Liang G, Leong R, Brown PA, Kaplan J, Schafer ES, Slone T, Pauly M, Chang BH, Stieglitz E, Wayne AS, Hijiya N, Bhojwani D. PMID: 38339248; PMCID: PMC10854518.
      View in: PubMed   Mentions:
    2. Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia. Haematologica. 2023 03 01; 108(3):747-760. Wayne AS, Huynh V, Hijiya N, Rouce RH, Brown PA, Krueger J, Kitko CL, Ziga ED, Hermiston ML, Richards MK, Baruchel A, Schuberth PC, Rossi J, Zhou L, Goyal L, Jain R, Vezan R, Masouleh BK, Lee DW. PMID: 36263840; PMCID: PMC9973494.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    3. Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001). Haematologica. 2022 10 01; 107(10):2295-2303. Tasian SK, Silverman LB, Whitlock JA, Sposto R, Loftus JP, Schafer ES, Schultz KR, Hutchinson RJ, Gaynon PS, Orgel E, Bateman CM, Cooper TM, Laetsch TW, Sulis ML, Chi YY, Malvar J, Wayne AS, Rheingold SR. PMID: 35112552; PMCID: PMC9521241.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    4. Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects. Cancer Immunol Res. 2022 07 01; 10(7):856-870. Ceppi F, Wilson AL, Annesley C, Kimmerly GR, Summers C, Brand A, Seidel K, Wu QV, Beebe A, Brown C, Mgebroff S, Lindgren C, Rawlings-Rhea SD, Huang W, Pulsipher MA, Wayne AS, Park JR, Jensen MC, Gardner RA. PMID: 35580141; PMCID: PMC9250626.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    5. Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. Pediatr Blood Cancer. 2022 10; 69(10):e29812. Schafer ES, Chao K, Stevens AM, Jo E, Hilsenbeck SG, Gossai NP, Doan A, Colace SI, Guinipero T, Otterson D, Kaplan JA, Hinson A, Pommert L, Wayne AS, Bhojwani D, Burke MJ. PMID: 35726868.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    6. Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium. Am J Hematol. 2022 05; 97(5):613-622. Pommert L, Schafer ES, Malvar J, Gossai N, Florendo E, Pulakanti K, Heimbruch K, Stelloh C, Chi YY, Sposto R, Rao S, Huynh VT, Brown P, Chang BH, Colace SI, Hermiston ML, Heym K, Hutchinson RJ, Kaplan JA, Mody R, O'Brien TA, Place AE, Shaw PH, Ziegler DS, Wayne A, Bhojwani D, Burke MJ. PMID: 35180323; PMCID: PMC8986610.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    7. Managing therapy-associated neurotoxicity in children with ALL. Hematology Am Soc Hematol Educ Program. 2021 12 10; 2021(1):376-383. Bhojwani D, Bansal R, Wayne AS. PMID: 34889354; PMCID: PMC8791096.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor. Mol Ther. 2022 03 02; 30(3):1215-1226. Fei F, Rong L, Jiang N, Wayne AS, Xie J. PMID: 34801727; PMCID: PMC8899520.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    9. In vitro and in vivo effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA-4, in B-cell acute lymphoblastic leukemia. Exp Ther Med. 2022 Jan; 23(1):47. Ruan Y, Kim HN, Ogana HA, Gang EJ, Li S, Liu HC, Bhojwani D, Wayne AS, Yang M, Kim YM. PMID: 34934426; PMCID: PMC8652384.
      View in: PubMed   Mentions: 2  
    10. Immunogenicity of CAR T cells in cancer therapy. Nat Rev Clin Oncol. 2021 06; 18(6):379-393. Wagner DL, Fritsche E, Pulsipher MA, Ahmed N, Hamieh M, Hegde M, Ruella M, Savoldo B, Shah NN, Turtle CJ, Wayne AS, Abou-El-Enein M. PMID: 33633361; PMCID: PMC8923136.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    11. A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation. Blood. 2021 02 18; 137(7):983-993. Qayed M, Ahn KW, Kitko CL, Johnson MH, Shah NN, Dvorak C, Mellgren K, Friend BD, Verneris MR, Leung W, Toporski J, Levine J, Chewning J, Wayne A, Kapoor U, Triplett B, Schultz KR, Yanik GA, Eapen M. PMID: 33206937; PMCID: PMC7918183.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    12. Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction. Pediatr Blood Cancer. 2021 01; 68(1):e28574. Shah NN, Schneiderman J, Kuruvilla D, Bhojwani D, Fry TJ, Martin PL, Schultz KR, Silverman LB, Whitlock JA, Wood B, Vainshtein I, Adams A, Confer D, Pulsipher MA, Chaudhury S, Wayne AS. PMID: 32959985.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia. Blood. 2020 07 09; 136(2):210-223. Gang EJ, Kim HN, Hsieh YT, Ruan Y, Ogana HA, Lee S, Pham J, Geng H, Park E, Klemm L, Willman CL, Carroll WL, Mittelman SD, Orgel E, Oberley MJ, Parekh C, Abdel-Azim H, Bhojwani D, Wayne AS, De Arcangelis A, Georges-Labouesse E, Wayner E, Bonig H, Minasyan A, Ten Hoeve J, Graeber TG, Müschen M, Heisterkamp N, Kim YM. PMID: 32219444; PMCID: PMC7357190.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimals
    14. CAR T-cell product performance in haematological malignancies before and after marketing authorisation. Lancet Oncol. 2020 02; 21(2):e104-e116. Elsallab M, Levine BL, Wayne AS, Abou-El-Enein M. PMID: 32007196; PMCID: PMC7841982.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    15. Disease detection methodologies in relapsed B-cell acute lymphoblastic leukemia: Opportunities for improvement. Pediatr Blood Cancer. 2020 04; 67(4):e28149. Shalabi H, Yuan CM, Kulshreshtha A, Dulau-Florea A, Salem D, Gupta GK, Roth M, Filie AC, Yates B, Delbrook C, Derdak J, Mackall CL, Lee DW, Fry TJ, Wayne AS, Stetler-Stevenson M, Shah NN. PMID: 31981407; PMCID: PMC7036332.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study. Clin Cancer Res. 2020 05 15; 26(10):2297-2307. Burke MJ, Kostadinov R, Sposto R, Gore L, Kelley SM, Rabik C, Trepel JB, Lee MJ, Yuno A, Lee S, Bhojwani D, Jeha S, Chang BH, Sulis ML, Hermiston ML, Gaynon P, Huynh V, Verma A, Gardner R, Heym KM, Dennis RM, Ziegler DS, Laetsch TW, Oesterheld JE, Dubois SG, Pollard JA, Glade-Bender J, Cooper TM, Kaplan JA, Farooqi MS, Yoo B, Guest E, Wayne AS, Brown PA. PMID: 31969338; PMCID: PMC7477726.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    17. Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemia. Pediatr Blood Cancer. 2020 05; 67(5):e28112. Shah NN, Bhojwani D, August K, Baruchel A, Bertrand Y, Boklan J, Dalla-Pozza L, Dennis R, Hijiya N, Locatelli F, Martin PL, Mechinaud F, Moppett J, Rheingold SR, Schmitt C, Trippett TM, Liang M, Balic K, Li X, Vainshtein I, Yao NS, Pastan I, Wayne AS. PMID: 31944549; PMCID: PMC7485266.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    18. Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells. J Extracell Vesicles. 2019; 8(1):1588538. Wu CH, Li J, Li L, Sun J, Fabbri M, Wayne AS, Seeger RC, Jong AY. PMID: 30891164; PMCID: PMC6419691.
      View in: PubMed   Mentions: 77     Fields:    
    19. Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia. Pediatr Blood Cancer. 2018 09; 65(9):e27265. Oberley MJ, Gaynon PS, Bhojwani D, Pulsipher MA, Gardner RA, Hiemenz MC, Ji J, Han J, O'Gorman MRG, Wayne AS, Raca G. PMID: 29797659; PMCID: PMC7469918.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    20. Domain II of Pseudomonas Exotoxin Is Critical for Efficacy of Bolus Doses in a Xenograft Model of Acute Lymphoblastic Leukemia. Toxins (Basel). 2018 05 21; 10(5). Müller F, Cunningham T, Beers R, Bera TK, Wayne AS, Pastan I. PMID: 29883379; PMCID: PMC5983266.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    21. Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study. Leukemia. 2018 11; 32(11):2316-2325. Sun W, Malvar J, Sposto R, Verma A, Wilkes JJ, Dennis R, Heym K, Laetsch TW, Widener M, Rheingold SR, Oesterheld J, Hijiya N, Sulis ML, Huynh V, Place AE, Bittencourt H, Hutchinson R, Messinger Y, Chang B, Matloub Y, Ziegler DS, Gardner R, Cooper T, Ceppi F, Hermiston M, Dalla-Pozza L, Schultz KR, Gaynon P, Wayne AS, Whitlock JA. PMID: 29728694; PMCID: PMC6224404.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    22. 5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotox. Proc Natl Acad Sci U S A. 2018 02 20; 115(8):E1867-E1875. Müller F, Cunningham T, Stookey S, Tai CH, Burkett S, Jailwala P, Stetler Stevenson M, Cam MC, Wayne AS, Pastan I. PMID: 29432154; PMCID: PMC5828592.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    23. A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortium. Blood. 2018 03 08; 131(10):1145-1148. Sun W, Triche T, Malvar J, Gaynon P, Sposto R, Yang X, Bittencourt H, Place AE, Messinger Y, Fraser C, Dalla-Pozza L, Salhia B, Jones P, Wayne AS, Gore L, Cooper TM, Liang G. PMID: 29339403; PMCID: PMC5863703.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    24. Cells to prevent/treat relapse following allogeneic stem cell transplantation. Hematology Am Soc Hematol Educ Program. 2017 12 08; 2017(1):708-715. Dietz AC, Wayne AS. PMID: 29222325; PMCID: PMC6142604.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    25. Investigating the biology of relapsed acute leukemia: Proceedings of the Therapeutic Advances for Childhood Leukemia & Lymphoma (TACL) Consortium Biology Working Group. Pediatr Hematol Oncol. 2017 Sep - Oct; 34(6-7):355-364. Bhojwani D, Burke MJ, Horton T, Ziegler DS, Sulis ML, Schultz KR, Wayne A, Izraeli S, Chang BH. PMID: 29190164; PMCID: PMC6191173.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Biological roles and potential applications of immune cell-derived extracellular vesicles. J Extracell Vesicles. 2017; 6(1):1400370. Wen C, Seeger RC, Fabbri M, Wang L, Wayne AS, Jong AY. PMID: 29209467; PMCID: PMC5706476.
      View in: PubMed   Mentions: 91     Fields:    
    27. Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL): Overview and introduction to the proceedings of the 2016 TACL investigator meeting. Pediatr Hematol Oncol. 2017 Sep - Oct; 34(6-7):349-354. Wayne AS, Shin-Kashiyama E, Sposto R, Gaynon P. PMID: 29120691; PMCID: PMC6122960.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. The American Society of Pediatric Hematology/Oncology workforce assessment: Part 1-Current state of the workforce. Pediatr Blood Cancer. 2018 Feb; 65(2). Hord J, Shah M, Badawy SM, Matthews D, Hilden J, Wayne AS, Salsberg E, Leavey PS, American Society of Pediatric Hematology/Oncology Workforce Advisory Taskforce. PMID: 29068564.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    29. The American Society of Pediatric Hematology/Oncology workforce assessment: Part 2-Implications for fellowship training. Pediatr Blood Cancer. 2018 Feb; 65(2). Leavey PJ, Hilden JM, Matthews D, Dandoy C, Badawy SM, Shah M, Wayne AS, Hord J, American Society of Pediatric Hematology/Oncology Workforce Advisory Taskforce. PMID: 29068565.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    30. Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantation. Bone Marrow Transplant. 2018 01; 53(1):1-2. Kröger N, Bishop M, Giralt S, Wayne A. PMID: 28991243.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    31. The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL. Cancers (Basel). 2017 Sep 10; 9(9). Adam E, Kim HN, Gang EJ, Schnair C, Lee S, Lee S, Khazal S, Kosoyan O, Konopleva M, Parekh C, Bhojwani D, Wayne AS, Abdel-Azim H, Heisterkamp N, Kim YM. PMID: 28891959; PMCID: PMC5615336.
      View in: PubMed   Mentions: 9  
    32. Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia. Blood. 2017 10 05; 130(14):1620-1627. Wayne AS, Shah NN, Bhojwani D, Silverman LB, Whitlock JA, Stetler-Stevenson M, Sun W, Liang M, Yang J, Kreitman RJ, Lanasa MC, Pastan I. PMID: 28983018; PMCID: PMC5630009.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    33. Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells. J Extracell Vesicles. 2017; 6(1):1294368. Jong AY, Wu CH, Li J, Sun J, Fabbri M, Wayne AS, Seeger RC. PMID: 28326171; PMCID: PMC5345580.
      View in: PubMed   Mentions: 112     Fields:    
    34. Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse. Biol Blood Marrow Transplant. 2016 12; 22(12):2149-2154. Shah NN, Loeb DM, Khuu H, Stroncek D, Ariyo T, Raffeld M, Delbrook C, Mackall CL, Wayne AS, Fry TJ. PMID: 27634018; PMCID: PMC7499897.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    35. Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia. Pediatr Blood Cancer. 2016 11; 63(11):1943-8. Sun W, Orgel E, Malvar J, Sposto R, Wilkes JJ, Gardner R, Tolbert VP, Smith A, Hur M, Hoffman J, Rheingold SR, Burke MJ, Wayne AS. PMID: 27437864; PMCID: PMC7451261.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    36. Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase Intolerance. J Pediatr Hematol Oncol. 2016 07; 38(5):345-9. Yeo KK, Gaynon PS, Fu CH, Wayne AS, Sun W. PMID: 27352191; PMCID: PMC7451259.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    37. Wide Variability in the Time Required for Immunotoxins to Kill B Lineage Acute Lymphoblastic Leukemia Cells: Implications for Trial Design. Clin Cancer Res. 2016 Oct 01; 22(19):4913-4922. Müller F, Cunningham T, Liu XF, Wayne AS, Pastan I. PMID: 27114443; PMCID: PMC5050065.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    38. Protein Kinase Inhibitor H89 Enhances the Activity of Pseudomonas Exotoxin A-Based Immunotoxins. Mol Cancer Ther. 2016 05; 15(5):1053-62. Liu X, Müller F, Wayne AS, Pastan I. PMID: 26939705; PMCID: PMC4873377.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    39. Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias. Pediatr Blood Cancer. 2016 Jun; 63(6):997-1005. Shah NN, Merchant MS, Cole DE, Jayaprakash N, Bernstein D, Delbrook C, Richards K, Widemann BC, Wayne AS. PMID: 26891067; PMCID: PMC6689398.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    40. Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primates. Invest New Drugs. 2016 Feb; 34(1):61-5. Shah NN, Cole DE, Lester-McCully CM, Wayne AS, Warren KE, Widemann BC. PMID: 26661090; PMCID: PMC6343835.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    41. Characterization of CD22 expression in acute lymphoblastic leukemia. Pediatr Blood Cancer. 2015 Jun; 62(6):964-9. Shah NN, Stevenson MS, Yuan CM, Richards K, Delbrook C, Kreitman RJ, Pastan I, Wayne AS. PMID: 25728039; PMCID: PMC4405453.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    42. Is another antibody conjugate against ALL needed? Lancet Haematol. 2015 Mar; 2(3):e87-8. Wayne AS, Pui CH. PMID: 26687801.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    43. Improving access to novel agents for childhood leukemia. Cancer. 2015 Jun 15; 121(12):1927-36. Sun W, Gaynon PS, Sposto R, Wayne AS. PMID: 25678105; PMCID: PMC4457598.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    44. Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation. Blood. 2015 Jan 29; 125(5):784-92. Shah NN, Baird K, Delbrook CP, Fleisher TA, Kohler ME, Rampertaap S, Lemberg K, Hurley CK, Kleiner DE, Merchant MS, Pittaluga S, Sabatino M, Stroncek DF, Wayne AS, Zhang H, Fry TJ, Mackall CL. PMID: 25452614; PMCID: PMC4311226.
      View in: PubMed   Mentions: 117     Fields:    Translation:HumansCellsCTClinical Trials
    45. Abnormal bone marrow histopathology in paediatric mastocytosis. Br J Haematol. 2015 Mar; 168(6):865-73. Carter MC, Metcalfe DD, Clark AS, Wayne AS, Maric I. PMID: 25429914; PMCID: PMC9254166.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    46. Children as hematopoietic cell donors in research: when is it approvable? Bone Marrow Transplant. 2015 Jan; 50(1):15-9. Shah NN, Wayne AS, Grady C, Fry T, Wendler D. PMID: 25330224.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    47. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. Lancet. 2015 Feb 07; 385(9967):517-528. Lee DW, Kochenderfer JN, Stetler-Stevenson M, Cui YK, Delbrook C, Feldman SA, Fry TJ, Orentas R, Sabatino M, Shah NN, Steinberg SM, Stroncek D, Tschernia N, Yuan C, Zhang H, Zhang L, Rosenberg SA, Wayne AS, Mackall CL. PMID: 25319501; PMCID: PMC7065359.
      View in: PubMed   Mentions: 1413     Fields:    Translation:HumansCellsCTClinical Trials
    48. New frontiers in pediatric Allo-SCT: novel approaches for children and adolescents with ALL. Bone Marrow Transplant. 2014 Oct; 49(10):1259-65. Pulsipher MA, Wayne AS, Schultz KR. PMID: 24933210.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    49. Factors predictive of relapse of acute leukemia in children after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2014 Jul; 20(7):1033-9. Shah NN, Borowitz MJ, Steinberg SM, Robey NC, Gamper CJ, Symons HJ, Loeb DM, Wayne AS, Chen AR. PMID: 24691222; PMCID: PMC4471051.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    50. Feasibility of treating post-transplantation minimal residual disease in children with acute leukemia. Biol Blood Marrow Transplant. 2014 Jul; 20(7):1000-7. Shah NN, Borowitz MJ, Robey NC, Gamper CJ, Symons HJ, Loeb DM, Wayne AS, Chen AR. PMID: 24680975; PMCID: PMC4077899.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    51. Immunotoxins for leukemia. Blood. 2014 Apr 17; 123(16):2470-7. Wayne AS, Fitzgerald DJ, Kreitman RJ, Pastan I. PMID: 24578503; PMCID: PMC3990911.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimals
    52. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: introduction. Biol Blood Marrow Transplant. 2013 Nov; 19(11):1534-6. Wayne AS, Giralt S, Kröger N, Bishop MR. PMID: 24035783; PMCID: PMC3880421.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    53. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies. Biol Blood Marrow Transplant. 2013 Dec; 19(12):1661-9. Avigan D, Hari P, Battiwalla M, Bishop MR, Giralt SA, Hardy NM, Kröger N, Wayne AS, Hsu KC. PMID: 24018393; PMCID: PMC3914636.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    54. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantation. Biol Blood Marrow Transplant. 2014 Jan; 20(1):4-13. de Lima M, Porter DL, Battiwalla M, Bishop MR, Giralt SA, Hardy NM, Kröger N, Wayne AS, Schmid C. PMID: 24018392; PMCID: PMC3938421.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCellsPHPublic Health
    55. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part I. Biology of relapse after transplantation. Biol Blood Marrow Transplant. 2013 Nov; 19(11):1537-45. Gress RE, Miller JS, Battiwalla M, Bishop MR, Giralt SA, Hardy NM, Kröger N, Wayne AS, Landau DA, Wu CJ. PMID: 24018395; PMCID: PMC3922045.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    56. Simplified process for the production of anti-CD19-CAR-engineered T cells. Cytotherapy. 2013 Nov; 15(11):1406-15. Tumaini B, Lee DW, Lin T, Castiello L, Stroncek DF, Mackall C, Wayne A, Sabatino M. PMID: 23992830; PMCID: PMC4141724.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    57. Methylation of the DPH1 promoter causes immunotoxin resistance in acute lymphoblastic leukemia cell line KOPN-8. Leuk Res. 2013 Nov; 37(11):1551-6. Hu X, Wei H, Xiang L, Chertov O, Wayne AS, Bera TK, Pastan I. PMID: 24070652; PMCID: PMC3818433.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    58. Immunotherapy for pediatric leukemia. Front Oncol. 2013; 3:166. Shah NN, Dave H, Wayne AS. PMID: 23847759; PMCID: PMC3696894.
      View in: PubMed   Mentions: 8  
    59. A modified form of diphthamide causes immunotoxin resistance in a lymphoma cell line with a deletion of the WDR85 gene. J Biol Chem. 2013 Apr 26; 288(17):12305-12. Wei H, Bera TK, Wayne AS, Xiang L, Colantonio S, Chertov O, Pastan I. PMID: 23486472; PMCID: PMC3636914.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    60. Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype. Pharmacotherapy. 2013 Mar; 33(3):e19-22. Moriyama B, Jarosinski PF, Figg WD, Henning SA, Danner RL, Penzak SR, Wayne AS, Walsh TJ. PMID: 23400848; PMCID: PMC3594083.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    61. Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies. PLoS One. 2012; 7(12):e52655. Dave H, Anver MR, Butcher DO, Brown P, Khan J, Wayne AS, Baskar S, Rader C. PMID: 23285131; PMCID: PMC3527582.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    62. Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia. Blood. 2013 Feb 14; 121(7):1165-74. Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ. PMID: 23243285; PMCID: PMC3575759.
      View in: PubMed   Mentions: 297     Fields:    Translation:HumansAnimalsCells
    63. Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans. Blood. 2012 Nov 01; 120(18):3635-46. Candotti F, Shaw KL, Muul L, Carbonaro D, Sokolic R, Choi C, Schurman SH, Garabedian E, Kesserwan C, Jagadeesh GJ, Fu PY, Gschweng E, Cooper A, Tisdale JF, Weinberg KI, Crooks GM, Kapoor N, Shah A, Abdel-Azim H, Yu XJ, Smogorzewska M, Wayne AS, Rosenblatt HM, Davis CM, Hanson C, Rishi RG, Wang X, Gjertson D, Yang OO, Balamurugan A, Bauer G, Ireland JA, Engel BC, Podsakoff GM, Hershfield MS, Blaese RM, Parkman R, Kohn DB. PMID: 22968453; PMCID: PMC3488882.
      View in: PubMed   Mentions: 111     Fields:    Translation:HumansCellsCTClinical Trials
    64. Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemia. J Clin Oncol. 2012 Nov 01; 30(31):3876-83. Kantarjian H, Thomas D, Wayne AS, O'Brien S. PMID: 22891271; PMCID: PMC3478578.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    65. Pretransplant MRD: the light is yellow, not red. Blood. 2012 Jul 12; 120(2):244-6. Wayne AS, Radich JP. PMID: 22791775.
      View in: PubMed   Mentions: 4     Fields:    
    66. Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy. Proc Natl Acad Sci U S A. 2012 May 01; 109(18):6898-903. Wei H, Xiang L, Wayne AS, Chertov O, FitzGerald DJ, Bera TK, Pastan I. PMID: 22509046; PMCID: PMC3345006.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    67. Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges. Am J Hematol. 2012 Sep; 87(9):916-22. Shah NN, Bacher U, Fry T, Calvo KR, Stetler-Stevenson M, Arthur DC, Kurlander R, Baird K, Wise B, Giralt S, Bishop M, Hardy NM, Wayne AS. PMID: 22473867; PMCID: PMC3454494.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    68. Bone marrow homing and engraftment of human hematopoietic stem and progenitor cells is mediated by a polarized membrane domain. Blood. 2012 Feb 23; 119(8):1848-55. Larochelle A, Gillette JM, Desmond R, Ichwan B, Cantilena A, Cerf A, Barrett AJ, Wayne AS, Lippincott-Schwartz J, Dunbar CE. PMID: 22228628; PMCID: PMC3293639.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    69. Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency. J Allergy Clin Immunol. 2012 Mar; 129(3):762-769.e1. Kesserwan C, Sokolic R, Cowen EW, Garabedian E, Heselmeyer-Haddad K, Lee CC, Pittaluga S, Ortiz C, Baird K, Lopez-Terrada D, Bridge J, Wayne AS, Candotti F. PMID: 22153773; PMCID: PMC3294021.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    70. Treatment of hematologic malignancies with immunotoxins and antibody-drug conjugates. Cancer Res. 2011 Oct 15; 71(20):6300-9. FitzGerald DJ, Wayne AS, Kreitman RJ, Pastan I. PMID: 21998010; PMCID: PMC3201758.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimals
    71. Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations. Clin Lymphoma Myeloma Leuk. 2012 Feb; 12(1):20-5. Mehta N, Wayne AS, Kim YH, Hale GA, Alvarado CS, Myskowski P, Jaffe ES, Busam KJ, Pulitzer M, Zwerner J, Horwitz S. PMID: 22001256; PMCID: PMC3938280.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    72. Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas. Biol Blood Marrow Transplant. 2012 May; 18(5):698-707. Baird K, Fry TJ, Steinberg SM, Bishop MR, Fowler DH, Delbrook CP, Humphrey JL, Rager A, Richards K, Wayne AS, Mackall CL. PMID: 21896345; PMCID: PMC3262116.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    73. Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency. Blood. 2011 Sep 08; 118(10):2688-94. Sokolic R, Maric I, Kesserwan C, Garabedian E, Hanson IC, Dodds M, Buckley R, Issekutz AC, Kamani N, Shaw K, Tan B, Bali P, Hershfield MS, Kohn DB, Wayne AS, Candotti F. PMID: 21725047; PMCID: PMC3172788.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    74. Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737. Leuk Lymphoma. 2011 Jun; 52 Suppl 2:79-81. Fitzgerald DJ, Moskatel E, Ben-Josef G, Traini R, Tendler T, Sharma A, Antignani A, Mussai F, Wayne A, Kreitman RJ, Pastan I. PMID: 21599608; PMCID: PMC7450489.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    75. Therapeutic antibiotic use patterns in dogs: observations from a veterinary teaching hospital. J Small Anim Pract. 2011 Jun; 52(6):310-8. Wayne A, McCarthy R, Lindenmayer J. PMID: 21627659; PMCID: PMC3106276.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimals
    76. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011 Jun 02; 117(22):5835-49. Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, Burbelo PD, Turk SP, Fulton R, Wayne AS, Little RF, Cairo MS, El-Mallawany NK, Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE. PMID: 21454450; PMCID: PMC3112034.
      View in: PubMed   Mentions: 117     Fields:    Translation:HumansCells
    77. Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells. J Immunother. 2011 Mar; 34(2):187-95. Zhang H, Cui Y, Voong N, Sabatino M, Stroncek DF, Morisot S, Civin CI, Wayne AS, Levine BL, Mackall CL. PMID: 21304401; PMCID: PMC3128544.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    78. National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee. Biol Blood Marrow Transplant. 2011 Apr; 17(4):443-54. Bishop MR, Alyea EP, Cairo MS, Falkenburg JH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter DL, Riddell SR, van Besien K, Wayne AS, Weisdorf DJ, Wu RS, Giralt S. PMID: 21224011; PMCID: PMC3102296.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    79. Variables affecting the quantitation of CD22 in neoplastic B cells. Cytometry B Clin Cytom. 2011 Mar; 80(2):83-90. Jasper GA, Arun I, Venzon D, Kreitman RJ, Wayne AS, Yuan CM, Marti GE, Stetler-Stevenson M. PMID: 20872890; PMCID: PMC7316386.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    80. High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias. Leukemia. 2010 Nov; 24(11):1859-66. Morisot S, Wayne AS, Bohana-Kashtan O, Kaplan IM, Gocke CD, Hildreth R, Stetler-Stevenson M, Walker RL, Davis S, Meltzer PS, Wheelan SJ, Brown P, Jones RJ, Shultz LD, Civin CI. PMID: 20739953; PMCID: PMC3035974.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    81. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2010 Nov; 16(11):1467-503. Porter DL, Alyea EP, Antin JH, DeLima M, Estey E, Falkenburg JH, Hardy N, Kroeger N, Leis J, Levine J, Maloney DG, Peggs K, Rowe JM, Wayne AS, Giralt S, Bishop MR, van Besien K. PMID: 20699125; PMCID: PMC2955517.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    82. Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica. 2010 Nov; 95(11):1873-9. Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, Jaffe ES. PMID: 20663945; PMCID: PMC2966909.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    83. Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy. Bone Marrow Transplant. 2011 May; 46(5):759-61. El-Mallawany NK, Geller L, Bollard CM, Wistinghausen B, Mussai F, Wayne AS, Alobeid B, Cairo MS. PMID: 20661233; PMCID: PMC3175617.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    84. NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies. Biol Blood Marrow Transplant. 2010 Oct; 16(10):1325-46. Kröger N, Bacher U, Bader P, Böttcher S, Borowitz MJ, Dreger P, Khouri I, Olavarria E, Radich J, Stock W, Vose JM, Weisdorf D, Willasch A, Giralt S, Bishop MR, Wayne AS. PMID: 20637879.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    85. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes. Biol Blood Marrow Transplant. 2010 Sep; 16(9):1187-211. Kröger N, Bacher U, Bader P, Böttcher S, Borowitz MJ, Dreger P, Khouri I, Macapinlac HA, Macapintac H, Olavarria E, Radich J, Stock W, Vose JM, Weisdorf D, Willasch A, Giralt S, Bishop MR, Wayne AS. PMID: 20558311; PMCID: PMC7272718.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    86. Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia. Br J Haematol. 2010 Aug; 150(3):352-8. Mussai F, Campana D, Bhojwani D, Stetler-Stevenson M, Steinberg SM, Wayne AS, Pastan I. PMID: 20528877; PMCID: PMC7316383.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    87. Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial. Clin Cancer Res. 2010 Mar 15; 16(6):1894-903. Wayne AS, Kreitman RJ, Findley HW, Lew G, Delbrook C, Steinberg SM, Stetler-Stevenson M, Fitzgerald DJ, Pastan I. PMID: 20215554; PMCID: PMC2840067.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    88. Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2010 May; 16(5):563-4. Bishop MR, Alyea EP, Cairo MS, Falkenburg JH, June CH, Kröger N, Little RF, Miller JS, Pavletic SZ, Porter D, Riddell SR, van Besien K, Wayne AS, Weisdorf DJ, Wu R, Giralt S. PMID: 20202482; PMCID: PMC2996879.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    89. The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma. Blood. 2010 Apr 15; 115(15):3017-24. Dunleavy K, Little RF, Pittaluga S, Grant N, Wayne AS, Carrasquillo JA, Steinberg SM, Yarchoan R, Jaffe ES, Wilson WH. PMID: 20130244; PMCID: PMC2858473.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansCellsCTClinical Trials
    90. Immune-based therapeutics for pediatric cancer. Expert Opin Biol Ther. 2010 Feb; 10(2):163-78. Capitini CM, Mackall CL, Wayne AS. PMID: 19947897; PMCID: PMC2809805.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    91. Immunotherapy of childhood cancer: from biologic understanding to clinical application. Curr Opin Pediatr. 2010 Feb; 22(1):2-11. Wayne AS, Capitini CM, Mackall CL. PMID: 19952749; PMCID: PMC2845444.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    92. Hematopoietic stem cell transplantation for leukemia. Pediatr Clin North Am. 2010 Feb; 57(1):1-25. Wayne AS, Baird K, Egeler RM. PMID: 20307709; PMCID: PMC2913522.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    93. Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia. Pediatr Blood Cancer. 2010 Jan; 54(1):173-5. Raygada M, Arthur DC, Wayne AS, Rennert OM, Toretsky JA, Stratakis CA. PMID: 19785027; PMCID: PMC2783853.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    94. Extracorporeal photo-apheresis for the treatment of steroid-resistant graft versus host disease. Transfus Apher Sci. 2009 Dec; 41(3):209-16. Baird K, Wayne AS. PMID: 19819186; PMCID: PMC2787192.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    95. Application of immunotherapy in pediatric leukemia. Curr Hematol Malig Rep. 2009 Jul; 4(3):159-66. Wayne AS. PMID: 20425429.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    96. Progress in the curative treatment of childhood hematologic malignancies. J Natl Cancer Inst. 2008 Sep 17; 100(18):1271-3. Wayne AS, Reaman GH, Helman LJ. PMID: 18780861.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    97. Sibling stem cell donor experiences at a single institution. Psychooncology. 2008 Mar; 17(3):304-7. Wiener LS, Steffen-Smith E, Battles HB, Wayne A, Love CP, Fry T. PMID: 17534868; PMCID: PMC2293127.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    98. Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: utility of PCR for early recognition and therapy. Pediatr Infect Dis J. 2008 Mar; 27(3):265-8. Rau R, Fitzhugh CD, Baird K, Cortez KJ, Li L, Fischer SH, Cowen EW, Balow JE, Walsh TJ, Cohen JI, Wayne AS. PMID: 18277922.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    99. Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients. J Proteomics. 2008 Apr 30; 71(1):61-70. Abbatiello SE, Pan YX, Zhou M, Wayne AS, Veenstra TD, Hunger SP, Kilberg MS, Eyler JR, Richards NG, Conrads TP. PMID: 18541474.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    100. Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation. Obstet Gynecol. 2007 Nov; 110(5):1041-9. Stratton P, Turner ML, Childs R, Barrett J, Bishop M, Wayne AS, Pavletic S. PMID: 17978118.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    101. Thromboembolic events in children and young adults with pediatric sarcoma. J Clin Oncol. 2007 Apr 20; 25(12):1519-24. Paz-Priel I, Long L, Helman LJ, Mackall CL, Wayne AS. PMID: 17442994.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    102. The transfusion of neutrophil-specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions. Transfusion. 2007 Mar; 47(3):545-50. Fadeyi EA, De Los Angeles Muniz M, Wayne AS, Klein HG, Leitman SF, Stroncek DF. PMID: 17319838.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    103. Hematopoietic stem cell donation in children: a review of the sibling donor experience. J Psychosoc Oncol. 2007; 25(1):45-66. Wiener LS, Steffen-Smith E, Fry T, Wayne AS. PMID: 17360315; PMCID: PMC2367259.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    104. Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma. Leukemia. 2007 Jan; 21(1):169-74. Ise T, Nagata S, Kreitman RJ, Wilson WH, Wayne AS, Stetler-Stevenson M, Bishop MR, Scheinberg DA, Rassenti L, Kipps TJ, Kyle RA, Jelinek DF, Pastan I. PMID: 17051241.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    105. Psychotropic medication use in pediatric patients with cancer. Arch Pediatr Adolesc Med. 2006 Aug; 160(8):818-22. Pao M, Ballard ED, Rosenstein DL, Wiener L, Wayne AS. PMID: 16894081.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    106. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant. 2006 Apr; 12(4):375-96. Couriel D, Carpenter PA, Cutler C, Bolaños-Meade J, Treister NS, Gea-Banacloche J, Shaughnessy P, Hymes S, Kim S, Wayne AS, Chien JW, Neumann J, Mitchell S, Syrjala K, Moravec CK, Abramovitz L, Liebermann J, Berger A, Gerber L, Schubert M, Filipovich AH, Weisdorf D, Schubert MM, Shulman H, Schultz K, Mittelman B, Pavletic S, Vogelsang GB, Martin PJ, Lee SJ, Flowers ME. PMID: 16545722.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansPHPublic Health
    107. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis. Biol Blood Marrow Transplant. 2006 Jan; 12(1 Suppl 2):22-30. Yamashita K, Horwitz ME, Kwatemaa A, Nomicos E, Castro K, Sokolic R, Foster SF, Garofalo M, Choi U, Ryherd M, Brown MR, Leitman SF, Wayne AS, Fowler DH, Bishop MR, Childs RW, Barrett AJ, Pavletic SZ, Malech HL. PMID: 16399598.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    108. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol. 2005 Jul 20; 23(21):4735-41. Strouse JJ, Fears TR, Tucker MA, Wayne AS. PMID: 16034049.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    109. Two novel CHS1 (LYST) mutations: clinical correlations in an infant with Chediak-Higashi syndrome. Mol Genet Metab. 2005 Jun; 85(2):125-32. Zarzour W, Kleta R, Frangoul H, Suwannarat P, Jeong A, Kim SY, Wayne AS, Gunay-Aygun M, White J, Filipovich AH, Gahl WA. PMID: 15896657.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    110. Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis. J Clin Oncol. 2004 Sep 15; 22(18):3798-804. Godder K, Eapen M, Laver JH, Zhang MJ, Camitta BM, Wayne AS, Gale RP, Doyle JJ, Yu LC, Chen AR, Garvin JH, Sandler ES, Yeager AM, Edwards JR, Horowitz MM. PMID: 15365077.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    111. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplant. 2004 May; 33(10):1031-5. Robinson MR, Lee SS, Rubin BI, Wayne AS, Pavletic SZ, Bishop MR, Childs R, Barrett AJ, Csaky KG. PMID: 15048138.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    112. Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens. Transfusion. 2004 Feb; 44(2):229-38. Bolan CD, Yau YY, Cullis HC, Horwitz ME, Mackall CL, Barrett AJ, Malech HL, Rehak NN, Wayne AS, Leitman SF. PMID: 14962314.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    113. Allogeneic hematopoietic stem cell transplantation for myeloproliferative disorders and myelodysplastic syndromes. Hematol Oncol Clin North Am. 2003 Oct; 17(5):1243-60. Wayne AS, Barrett AJ. PMID: 14560785.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    114. Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences. Cytotherapy. 2002; 4(6):539-49. Khuu HM, Cowley H, David-Ocampo V, Carter CS, Kasten-Sportes C, Wayne AS, Solomon SR, Bishop MR, Childs RM, Read EJ. PMID: 12568990.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsPHPublic Health
    115. Financial analysis of chronic transfusion for stroke prevention in sickle cell disease. Blood. 2000 Oct 01; 96(7):2369-72. Wayne AS, Schoenike SE, Pegelow CH. PMID: 11001885.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    116. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood. 2000 Mar 15; 95(6):1918-24. Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE, Buchanan GE, Rogers ZR, Dinndorf P, Davies SC, Roberts IA, Dickerhoff R, Yeager AM, Hsu L, Kurtzberg J, Ohene-Frempong K, Bunin N, Bernaudin F, Wong WY, Scott JP, Margolis D, Vichinsky E, Wall DA, Wayne AS, Pegelow C, Redding-Lallinger R, Wiley J, Klemperer M, Mentzer WC, Smith FO, Sullivan KM. PMID: 10706855.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCTClinical Trials
    117. Nucleoside analogues in the therapy of Langerhans cell histiocytosis: a survey of members of the histiocyte society and review of the literature. Med Pediatr Oncol. 1999 Nov; 33(5):476-81. Weitzman S, Wayne AS, Arceci R, Lipton JM, Whitlock JA. PMID: 10531572.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    118. Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions. Biol Blood Marrow Transplant. 1997 Dec; 3(6):310-5. Walters MC, Patience M, Leisenring W, Rogers ZR, Dinndorf P, Davies SC, Roberts IA, Yeager A, Kurtzberg J, Bunin N, Scott JP, Wall DA, Wayne AS, Wiley J, Darbyshire PJ, Mentzer WC, Smith FO, Sullivan KM. PMID: 9502298.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    119. Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant. 1996 May; 2(2):100-4. Walters MC, Patience M, Leisenring W, Eckman JR, Buchanan GR, Rogers ZR, Olivieri NE, Vichinsky E, Davies SC, Mentzer WC, Powars D, Scott JP, Bernaudin F, Ohene-Frempong K, Darbyshire PJ, Wayne A, Roberts IA, Dinndorf P, Brandalise S, Sanders JE, Matthews DC, Appelbaum FR, Storb R, Sullivan KM. PMID: 9118298.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    120. Recipient T-cell immune reconstitution in X-linked SCID after haploidentical maternal bone marrow transplant. Ann N Y Acad Sci. 1995 Dec 29; 770:376-7. de la Morena MT, Wayne AS, Day NK, Haag MM, Hinds-Frey KR, Nelson RP, Sutcliffe MJ, Good RA. PMID: 8597380.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    121. Clonality in juvenile chronic myelogenous leukemia. Blood. 1995 Jan 01; 85(1):21-30. Busque L, Gilliland DG, Prchal JT, Sieff CA, Weinstein HJ, Sokol JM, Belickova M, Wayne AS, Zuckerman KS, Sokol L, et al. PMID: 7803795.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    122. Total hip arthroplasty in beta-thalassemia. Case report and review of the literature. Clin Orthop Relat Res. 1993 Sep; (294):149-54. Wayne AS, Zelicof SB, Sledge CB. PMID: 8358907.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    123. Transfusion management of sickle cell disease. Blood. 1993 Mar 01; 81(5):1109-23. Wayne AS, Kevy SV, Nathan DG. PMID: 8443373.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    124. Perioperative management for cholecystectomy in sickle cell disease. J Pediatr Surg. 1993 Jan; 28(1):72-5. Bhattacharyya N, Wayne AS, Kevy SV, Shamberger RC. PMID: 8429477.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    125. Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents. J Clin Oncol. 1993 Jan; 11(1):84-90. West DC, Shamberger RC, Macklis RM, Kozakewich HP, Wayne AS, Kreissman SG, Korf BR, Lavally B, Grier HE. PMID: 8418247.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    126. Desferrioxamine provocative test: methodology for estimating iron and total iron binding capacity. Blood. 1990 Nov 15; 76(10):2162. Fosburg M, Nathan D, Wayne A. PMID: 2242435.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    127. Treatment of Cooley's anemia: deferoxamine provocation test. Blood. 1990 Nov 01; 76(9):1897. Fosburg M, Nathan D, Wayne A. PMID: 2224141.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    128. The evaluation of diagnostic tests for cancer; inhibition of serum alkaline phosphate by zinc ion; the Roche test. Cancer Res. 1949 Nov; 9(11):681-3. FISHMAN WH, WAYNE A, HOMBURGER F. PMID: 15392835.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Alan's Networks
    Concepts (555)
    Derived automatically from this person's publications.
    _
    Co-Authors (31)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _